Please login to the form below

Not currently logged in

Q1 sales

This page shows the latest Q1 sales news and features for those working in and with pharma, biotech and healthcare.

AZ raises full-year guidance after completing Alexion acquisition in Q2

AZ raises full-year guidance after completing Alexion acquisition in Q2

In Q2, revenue increased by 17% to $7.3bn when excluding COVID-19 vaccine sales. ... Sales of its COVID-19 vaccine – sold under the Vaxzevria brand name in Europe – reached $894m in Q2, up from Q1 sales of $275m.

Latest news

More from news
Approximately 1 fully matching, plus 51 partially matching documents found.

Subscribe to our email news alerts

Featured jobs


Add my company
Create Health

A specialist Advertising and Med Comms agency dedicated to bringing much-needed creativity to healthcare marketing. We believe that brilliant ideas...

Latest intelligence

World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
Strategic behaviour
Strong strategising depends on your colleagues’ behaviour...
Pharmaceutical Marketing Strategies For The Digital Age
In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...